carmustine has been researched along with Dermatitis Medicamentosa in 3 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Excerpt | Relevance | Reference |
---|---|---|
"the severity of oral mucositis was less than would be expected in these patients without anti-mucositis therapy." | 2.72 | Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience. ( Horvath, N; Keefe, D; Lees, J, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keefe, D | 1 |
Lees, J | 1 |
Horvath, N | 1 |
Duvic, M | 1 |
Zackheim, HS | 1 |
Epstein, EH | 1 |
Grekin, DA | 1 |
1 review available for carmustine and Dermatitis Medicamentosa
Article | Year |
---|---|
Current treatment of Cutaneous T-Cell Lymphoma.
Topics: Administration, Oral; Administration, Topical; Anticarcinogenic Agents; Apoptosis; Bexarotene; Biops | 2001 |
1 trial available for carmustine and Dermatitis Medicamentosa
Article | Year |
---|---|
Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cancer Care | 2006 |
1 other study available for carmustine and Dermatitis Medicamentosa
Article | Year |
---|---|
Treatment of mycosis fungoides with topical BCNU.
Topics: Administration, Topical; Bone Marrow; Carmustine; Drug Eruptions; Humans; Mycosis Fungoides; Remissi | 1979 |